Centuple Global
Ticker > Company >

Centuple Global share price

Centuple Global Ltd.

BSE: 531099 SECTOR: Trading  9.1 K   2   0

45.00
+1.54 (3.54%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 45

Today's Low

₹ 41.5

52 Week High

₹ 144.4

52 Week Low

₹ 16.06

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 24.61 Cr.

Enterprise Value

₹ 24.58 Cr.

No. of Shares

0.55 Cr.

P/E

12

P/B

9.66

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  4.66

CASH

₹ 0.03 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

0 %

EPS (TTM)

₹  3.75

Sales Growth

-55.75%

ROE

4.66 %

ROCE

9.64%

Profit Growth

-15.89 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-55.75%
3 Year-37.12%
5 Year-12.73%

Profit Growth

1 Year-15.89%
3 Year39.17%
5 Year-4.25%

ROE%

1 Year4.66%
3 Year-8.38%
5 Year-7.41%

ROCE %

1 Year9.64%
3 Year0.36%
5 Year-0.25%

Debt/Equity

0

Price to Cash Flow

126.97

Interest Cover Ratio

10.1154

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2026 0.00 0.00
Dec 2025 0.00 0.00
Sep 2025 0.00 0.00
Jun 2025 0.00 0.00
Mar 2025 0.00 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company has a healthy liquidity position with current ratio of 6.9194.

 Limitations

  • The company has shown a poor revenue growth of -37.1198733400147% for the Past 3 years.
  • Company has a poor ROE of -8.3775722701499% over the past 3 years.
  • Company has a poor ROCE of 0.3596437850998% over the past 3 years
  • Company has high debtor days of 362.1895.
  • The company has a low EBITDA margin of 1.78104909498403% over the past 5 years.
  • The company is trading at a high PE of 12.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 0.1 0.25 11.71 108.59 174.09
Total Expenditure 0.14 0.16 11.62 106.8 173.32
Operating Profit -0.04 0.09 0.09 1.8 0.77
Other Income 0 0 0 0 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0.02 -0.02 0 0 0
Profit Before Tax -0.02 0.07 0.09 1.8 0.77
Tax 0 0.01 0 0.47 0.19
Profit After Tax -0.02 0.06 0.09 1.32 0.58
Adjusted EPS (Rs) -0.03 0.11 0.16 2.42 1.05

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 0.49 2.01 1.16 1.13 0.5
Total Expenditure 0.48 2.03 1.24 1.1 0.44
Operating Profit 0.01 -0.02 -0.08 0.03 0.06
Other Income 0 0 0 0 0
Interest 0 0 0 0 0.01
Depreciation 0 0 0 0.01 0.01
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.01 -0.02 -0.08 0.02 0.05
Tax 0 0.01 0 -0.01 0.02
Net Profit 0.01 -0.04 -0.08 0.03 0.03
Adjusted EPS (Rs.) 0.01 -0.07 -0.14 0.06 0.05

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 5.47 5.47 5.47 5.47 5.47
Total Reserves -4.85 -4.89 -4.97 -4.94 -4.91
Borrowings 0 0 0 0 0
Other N/C liabilities 0 0 0 -0.01 0
Current liabilities 0.29 0.27 0.16 0.4 0.09
Total Liabilities 0.9 0.85 0.66 0.93 0.65
Assets
Net Block 0.01 0.01 0.06 0.07 0
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 0.89 0.83 0.6 0.86 0.65
Total Assets 0.9 0.85 0.66 0.93 0.65
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 0.01 -0.02 -0.08 0.02 0.05
Adjustment 0 0 0 0.01 0.05
Changes in Assets & Liabilities 0.51 -0.47 0.09 -0.03 0.09
Tax Paid 0 -0.01 0 0 0
Operating Cash Flow 0.52 -0.5 0.01 0 0.19
Investing Cash Flow 0 0 0 -0.01 -0.18
Financing Cash Flow 0 0 0 0 0
Net Cash Flow 0.52 -0.5 0.01 -0.02 0.01

Corporate Actions

Investors Details

 No Promoters Data available for this company.Report us
PARTICULARS Mar 2025% Jun 2025% Sep 2025% Dec 2025% Mar 2026%
investors 100.00 100.00 100.00 100.00 100.00
aditya baid 2.93 2.93 2.93 2.93 2.93
aman baid 1.83 1.83 1.83 1.83 1.83
amay vatsalya 3.83 4.08 4.08 4.10 4.26
ankit mehra 4.25 4.25 2.56 2.56 2.56
binaikumar suresh prasad ... - - - 1.12 1.12
chandraprakash jamnalal k... - - - - 1.01
charu mehra 3.44 3.33 3.33 3.33 3.33
gatraj jain 3.66 3.66 3.66 3.66 3.66
golden bio energy limited... 3.91 4.30 3.39 3.39 3.87
m7 global fund pcc - cell... 5.48 5.48 5.48 5.48 5.48
malini pradeep saxena - - - 1.77 1.77
meena baid 2.74 2.74 2.74 2.74 2.74
nova global opportunities... 5.37 5.37 5.37 5.23 3.11
pradeep saxena - - 2.79 2.79 2.79
rajvansh electricals priv... 2.94 3.27 1.44 1.44 1.44
rakesh baid 3.66 3.66 3.66 3.66 3.66
religare finvest ltd 5.89 5.89 5.89 5.89 5.89
srinivasa rao isakalapale... - - - 1.07 -
tara devi toshniwal 1.35 1.34 - - -

Annual Reports

Title Link
Title Link
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Centuple Global informs about EGM 25 May, 5:25 PM Centuple Global informs about board meeting 20 May, 2:23 PM Checkpoint Trends informs about clarification 24 Apr, 3:56 PM Rubra Medicaments - Quaterly Results 29 Jan, 12:00 AM Checkpoint Trends informs about outcome of board meeting 28 Jan, 5:35 PM Checkpoint Trends informs about compliances-certificate 14 Jan, 4:14 PM Checkpoint Trends submits newspaper publication 23 Dec, 9:38 AM Checkpoint Trends informs about closure of trading window 20 Sep, 4:44 PM Checkpoint Trends informs about newspaper publication 4 Sep, 12:34 PM Rubra Medicaments - Quaterly Results 6 Aug, 5:16 PM Rubra Medicaments - Quaterly Results 6 Aug, 5:16 PM Rubra Medicaments - Quaterly Results 6 Aug, 5:16 PM Checkpoint Trends informs about disclosure 22 Apr, 3:42 PM Checkpoint Trends informs about disclosure 22 Apr, 3:36 PM Checkpoint Trends informs about postal ballot notice 16 Apr, 12:42 PM Checkpoint Trends informs about proceedings of EGM 12 Feb, 5:21 PM Rubra Medicaments - Quaterly Results 12 Feb, 5:15 PM Checkpoint Trends informs about disclosure 3 Feb, 3:14 PM Rubra Medicaments - Quaterly Results 11 Nov, 12:00 PM Rubra Medicaments - Quaterly Results 11 Nov, 12:00 PM Rubra Medicaments - Quaterly Results 11 Nov, 12:00 PM Checkpoint Trends submit scrutinizer report 1 Oct, 5:24 PM Checkpoint Trends informs about press release 11 Sep, 4:51 PM Checkpoint Trends informs about newspaper publication 19 Aug, 1:02 PM Rubra Medicaments - Quaterly Results 13 Aug, 5:36 PM Rubra Medicaments - Quaterly Results 13 Aug, 5:36 PM Rubra Medicaments - Quaterly Results 25 May, 3:02 PM Rubra Medicaments - Quaterly Results 25 May, 3:02 PM Rubra Medicaments - Quaterly Results 25 May, 3:02 PM Checkpoint Trends submits intimation of expiry of term of managing director 16 May, 2:51 PM Checkpoint Trends submits board meeting intimation 16 May, 12:13 PM Checkpoint Trends informs about newspapers advertisement 12 Feb, 1:25 PM Rubra Medicaments - Quaterly Results 7 Feb, 3:45 PM Rubra Medicaments - Quaterly Results 7 Feb, 3:45 PM Rubra Medicaments - Quaterly Results 7 Feb, 3:45 PM Rubra Medicaments - Quaterly Results 7 Nov, 2:38 PM Rubra Medicaments - Quaterly Results 7 Nov, 2:38 PM Checkpoint Trends submits intimation for notice of board meeting 28 Oct, 12:16 PM Checkpoint Trends informs about newspaper publication 17 Aug, 5:02 PM Checkpoint Trends informs about board meeting 2 Aug, 5:07 PM Rubra Medicaments informs about trading window closure 28 Dec, 3:16 PM Checkpoint Trends informs about outcome of board meeting 14 Nov, 2:05 PM Rubra Medicaments - Quaterly Results 10 Nov, 3:37 PM Rubra Medicaments - Quaterly Results 10 Nov, 3:37 PM Checkpoint Trends informs about board meeting 28 Oct, 10:42 AM Rubra Medicaments informs about annual report 3 Sep, 12:49 PM Rubra Medicaments informs about board meeting 1 Aug, 5:00 PM Rubra Medicaments informs about certificate 2 Jun, 11:51 AM Checkpoint Trends informs about newspaper publication 28 May, 11:40 AM Rubra Medicaments - Quaterly Results 25 May, 4:37 PM

Centuple Global Stock Price Analysis and Quick Research Report. Is Centuple Global an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Centuple Global. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Centuple Global has a PE ratio of 12.0035210328363 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Centuple Global has ROA of 3.2178% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Centuple Global has a Current ratio of 6.9194.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Centuple Global has a ROE of 4.6563%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Centuple Global has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Centuple Global has reported revenue growth of -55.7522% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Centuple Global for the current financial year is 11.84%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Centuple Global is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Centuple Global is Rs 3.7489. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Centuple Global in Ticker for free. Also, one can get the intrinsic value of Centuple Global by using Valuation Calculators, which are available with a Finology ONE subscription. 

Centuple Global FAQs

Q1. What is Centuple Global share price today?
Ans: The current share price of Centuple Global is Rs 45.

Q2. What is the market capitalisation of Centuple Global?
Ans: Centuple Global has a market capitalisation of Rs 24.60735 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Centuple Global?
Ans: The PE ratio of Centuple Global is 12.0035210328363 and the P/B ratio of Centuple Global is 9.66432575220669, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Centuple Global share?
Ans: The 52-week high share price of Centuple Global is Rs 144.4, and the 52-week low share price of Centuple Global is Rs 16.06.

Q5. Does Centuple Global pay dividends?
Ans: Currently, Centuple Global does not pay dividends. Dividend yield of Centuple Global is around 0%.

Q6. What are the face value and book value of Centuple Global shares?
Ans: The face value of Centuple Global shares is Rs 10, while the book value per share of Centuple Global is around Rs 4.6563. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Centuple Global?
Ans: Centuple Global has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Centuple Global?
Ans: The ROE of Centuple Global is 4.6563% and ROCE of Centuple Global is 9.6425%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Centuple Global a good buy for the long term?
Ans: The Centuple Global long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Centuple Global undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Centuple Global appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Centuple Global’s financials?
Ans: You can review Centuple Global’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Centuple Global
X